Compare Chitose Internasional Tbk. (CINT) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Chitose Internasional Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Chitose Internasional Tbk. trades at Rp166 (market cap 166B, 4.9K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp147 (market cap 576.7B, 3.18M 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 3.5× Chitose Internasional Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (3.18M versus 4.9K). Which is the better fit depends on your goals.
| CINT | LABS | |
|---|---|---|
Market Cap | 166B | 576.7B |
Volume | 4.9K | 3.18M |
Lot | 49 | 31.8K |
Turnover | 820.6K | 478.24M |
Average Price | 167.47 | 150.39 |
Value | 820.6K | 478.24M |
Indicative Equilibrium Price | — | 147 |
Indicative Equilibrium Volume | — | 311 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Chitose Internasional Tbk.
PT Chitose Internasional Tbk (the Company) formerly PT Chitose Indonesia Manufacturing was established based on Notarial Deed No. 21 dated June 15, 1978 of Widyanto Pranamihardja, S.H., notary in Bandung. The name was changed to PT Chitose Internasional on October 4, 2013. The company with brand Chitose has a high market share in all product categories, including folding chair, hotel, restaurant, food coourt, office and working chair and chair school.
Read more on CINT →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
